
Nuvectis Pharma, Inc.
NASDAQNVCT put-call ratio spikes to 0.0305, a 4.0-sigma jump above its 20-day mean of 0.0133, signaling extreme call dominance ahead of tomorrow's earnings release.
Snapshot as of 6 May 2026
No long-form analysis yet for NVCT. Pulse alerts and the live data picture are available on ORTEX.
Open NVCT on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NVCT — free to start on ORTEX.
Sign up for free →Open NVCT on ORTEX